Q32 Bio (QTTB) filed a registration statement Thursday for the potential sale of up to $300 million in securities from time to time in one or more offerings.

The filing covers common and preferred stock, debt securities, warrants and units.

Net proceeds will be used for general corporate purposes, the company said.